Celator Pharmaceuticals, Inc.
(NASDAQ : CPXX)

( )
CPXX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.46%44.570.9%$933.06m
JNJJohnson & Johnson
2.11%139.440.6%$907.00m
MRKMerck & Co., Inc.
0.81%71.800.6%$601.93m
LLYEli Lilly and Company
2.29%113.571.0%$528.31m
ABBVAbbVie, Inc.
0.33%92.212.2%$497.27m
BMYBristol-Myers Squibb Company
1.85%58.901.4%$359.83m
NVSNovartis AG Sponsored ADR
-0.44%85.340.2%$182.89m
AZNAstraZeneca PLC Sponsored ADR
0.56%39.301.3%$155.01m
NVONovo Nordisk A/S Sponsored ADR Class B
0.23%43.490.1%$88.11m
GSKGlaxoSmithKline plc Sponsored ADR
-0.15%39.740.2%$87.95m
SNYSanofi Sponsored ADR
0.77%44.690.2%$59.78m
LCILannett Company, Inc.
-0.96%4.1237.0%$6.82m
AKTXAkari Therapeutics Plc Sponsored ADR
9.09%1.921.7%$0.17m
EPIXESSA Pharma Inc
-4.94%3.710.1%$0.04m

Company Profile

Celator Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of biopharmaceutical products. It intends to provide chemotherapies and molecularly targeted agents to deliver anti-cancer activity and enhance treatment outcomes for cancer patients. It operates under the CombiPlex platform. Its products include VYXEOS, CPX-1, and CPX-8. The company was founded by Lawrence David Mayer and Marcel B. Bally in 1999 and is headquartered in Ewing, NJ.